Dr. Blum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd NE
Bldg C
Atlanta, GA 30322Phone+1 404-778-7408
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2000 - 2003
University of Virginia Medical CenterResidency, Internal Medicine, 1997 - 2000
Medical College of Georgia at Augusta UniversityClass of 1997
Certifications & Licensure
GA State Medical License 2017 - 2024
OH State Medical License 2003 - 2019
VA State Medical License 1997 - 2002- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2006 Mar 01
- Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. Start of enrollment: 2007 Apr 01
- Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsHigh early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.Karilyn T Larkin, Deedra Nicolet, Benjamin J Kelly, Krzysztof Mrózek, Stephanie LaHaye
Blood Advances. 2022-10-11 - 89 citationsLenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia c...Rosa Lapalombella, Bo Yu, Georgia Triantafillou, Qing Liu, Jonathan P. Butchar
Blood. 2008-12-15 - 71 citationsEpigenetics in acute myeloid leukemia.Christoph Plass, Christopher C. Oakes, William Blum, Guido Marcucci
Seminars in Oncology. 2008-08-01
Abstracts/Posters
- Newly Diagnosed AML Patient Samples Demonstrate High Degree of Concordance in Identification of Pathogenic Mutations By Next Generation Sequencing (NGS) Performed at E...William Blum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant AbstractWilliam Blum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Prevalence of Inherited Cancer Predisposition Mutations in a Cohort of Older AML Patients Enrolled on the Beat AML Master TrialWilliam Blum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Children’s Healthcare of Atlanta Opens First Clinical Trial for New Therapy Targeting LeukemiaApril 12th, 2023
COVID-19 Timeline Exposes Falsehood of US and US Lackey Australian Anti-China Blame GameMay 21st, 2020
Per Capita Covid-19 Deaths in Anglosphere 5-Eyes Intelligence-Sharing Nations Correlate with Neoliberal GreedMay 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
